COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUBSECTION 85 (2AA)
No. PB 15 of 1997
I, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:
- This Declaration shall come into operation on 1 November 1997.
2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.
THE SCHEDULE
Alprenolol Hydrochloride
Aluminium Hydroxide, Dried
Amorolfine Hydrochloride
Clofibrate
Fluphenazine Hydrochloride
Hyoscyamine Hydrobromide with Atropine Sulfate and Hyoscine Hydrobromide
Hyoscyamine Sulfate with Atropine Sulfate and Hyoscine Hydrobromide
Methyclothiazide
Methyl Salicylate
Metolazone
Promethazine Theoclate
Terbinafine Hydrochloride
Arachis Oil B.P.
Beeswax, White B.P.
Borax B.P.
Calamine B.P.
Camphor Spirit, Compound A.P.F.
Cetomacrogol Emulsifying Wax B.P.
Cetrimide B.P.
Emulsifying Wax B.P.
Ichthammol B.P.
Lobelia Tincture, Ethereal B.P.C. 1973
Methyl Salicylate B.P.
Methyl Salicylate Ointment, Compound A.P.F. 1934
Soap, Soft B.P.
Stramonium Tincture B.P. 1980
Tolu Syrup B.P.
Turpentine Liniment B.P.
Turpentine Oil B.P.
_____________________________________________________________________
Dated this 13th day of October 1997.
D. GRAHAM
Assistant Secretary
Pharmaceutical Benefits Branch
Department of Health and Family Services
Delegate of the Minister for Health and Family Services